Antiviral Cleansing

Plasma treatment appears to be cause of hyperfibrinolysis in transplant recipients

Published in Hepatitis Weekly, June 24th, 2002

by Sonia Nichols, senior medical writer - Procedures used for ridding plasma of viral contaminants may be causing liver transplant recipients to develop hyperfibrinolysis after transplantation.

Doctors in the Netherlands have reported observing more cases of hyperfibrinolysis among their liver transplant recipients who received treated plasma than among those who received fresh frozen plasma. Follow-up studies conducted by those physicians suggest the virus inactivation process, consisting of a solvent/detergent treatment procedure known as ESDEP, was the source of their observations.

ESDEP is used for ridding blood products of viral contaminants...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2002-06-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry